TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 131 resultados LastUpdate Última actualización 17/01/2022 [09:47:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



previousPage Página2 de 6 nextPage   por página


Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-4R) Antibodies

NºPublicación: US2021403581A1 30/12/2021

Solicitante:

REGENERON PHARMA [US]

MX_2019008084_A

Resumen de: US2021403581A1

The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-4 receptor (hIL-4R). The formulations may contain, in addition to an anti-hIL-4R antibody, at least one amino acid, at least one sugar, or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.

traducir

INSULIN DELIVERY ARRANGEMENT AND METHOD FOR INSULIN DOSING

NºPublicación: EP3927399A1 29/12/2021

Solicitante:

MYSUGR GMBH [AT]

US_2021369969_A1

Resumen de: WO2020169706A1

The invention concerns an insulin delivery arrangement (10) comprising a hand-operable insulin delivery device (12) which includes an adjusting unit (14) for presetting of an insulin dose and an applicator unit (24) that can be triggered to deliver the preset insulin dose to a user. In order to ease burden of insulin dosing, a dose converter (16) is adapted to receive an actual setting for the insulin dose as an input and to provide as an output a carbohydrate value equivalent to an amount of meal carbohydrates which can be compensated by the respective insulin dose, and a display (20, 20', 20'') is used for displaying the carbohydrate value in parallel to the insulin dose.

traducir

EVENT-DRIVEN COMPENSATED INSULIN DELIVERY OVER TIME

NºPublicación: WO2021257952A1 23/12/2021

Solicitante:

CAPILLARY BIOMEDICAL INC [US]

Resumen de: WO2021257952A1

Embodiments of systems and methods for delivering a medicament using a pump are provided. The methods comprise inserting a first cannula into subcutaneous tissue. Medicament is delivered from a medicament pump through the first cannula according to a dosing protocol. The first cannula can removed after a period of time and a second cannula can be inserted. The method comprises modifying the dosing protocol based upon a cannula change indicator, the modifying comprising performing neural network calculations utilizing previously calculated error data, resulting in a modified dosing protocol. Medicament is delivered from the medicament pump through the second cannula according to the modified dosing protocol.

traducir

Default carbohydrate consumption counts based on characteristics of persons

NºPublicación: US2021393876A1 23/12/2021

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2021398639_A1

Resumen de: US2021393876A1

The present disclosure relates to default carbohydrate consumption counts based on characteristics of persons. Aspects of the present disclosure relate to accessing at least one characteristic of a person, obtaining a default carbohydrate consumption count for the person based on the at least one characteristic of the person, and causing delivery of insulin to the person based on the default carbohydrate consumption count.

traducir

DIVERSIFIED GLUCOSE SENSOR SYSTEM

NºPublicación: US2021393174A1 23/12/2021

Solicitante:

CHASE ARNOLD [US]

WO_2019156714_A1

Resumen de: US2021393174A1

A diversified glucose sensor system comprises an introducer needle and two or more independent sensor bodies, each sensor body having one or more sensing elements that can be subcutaneously positioned in a patient's body by insertion of the introducer needle for glucose measurement. The system further includes a progressive insertion device comprising an insertion shaft that pushes the sensor bodies out the end opening of the introducer needle to a desired depth in the patient prior to removal of the insertion shaft and the introducer needle. The sensor bodies are bent or folded and held under stress within the introducer needle for insertion, and released and biased outwardly when pushed out of the introducer needle. The sensing elements are anchored and disposed within the patient at positions providing X/Y/Z-axis diversity for measurement.

traducir

Amalgamating wireless medical technology into a medical kit

NºPublicación: AU2021107420A4 23/12/2021

Solicitante:

HAMLIN LUKE

Resumen de: AU2021107420A4

2021107420 Amalgamating wireless medical technology into a medical kit Abstract A medical kit designed to centralise wireless technologies into a kit to support health practitioners in the health system. The medical kit comprises: 1. case; II. a tablet comprising a program that records information from the medical equipment and uses artificial intelligence to assist in the diagnosis of information being transmitted to the tablet; Ill. Wireless stethoscope IV. Wireless ECG V. Wireless Otoscope VI. Wireless Dermatoscope VII. Wireless Ophthalmoscope VIII. Glucose monitoring IX. BP monitoring X. Genetic testing kits (optional) XI. Smart glasses (optional)

traducir

Stabilized medical device and method for making it

NºPublicación: AU2020283745A1 23/12/2021

Solicitante:

W L GORE & ASSOCIATES INC

WO_2020242967_A1

Resumen de: AU2020283745A1

The present disclosure relates generally to stabilized medical devices having immobilized biologically active entities necessary for sterilization. The present disclosure provides a substrate (200) that is at least partially electrically conductive, and a stabilized enzyme layer (220) disposed over at least a portion of a surface of the substrate. The stabilized enzyme layer (220) may include at least one biologically active sensing component (240), such as glucose oxidase in the case of glucose sensors, and at least one stabilizing component (260) non-covalently combined with the biologically active sensing component (240). The present disclosure further provides the biologically active sensing component (240) having a biological activity detection level from about 25 U/cm3 to about 1,000,000 11/ cm3 of the substrate following ethylene oxide sterilization of the biologically active sensing component. The present disclosure further provides methods of making stabilized medical devices having immobilized biologically active entities.

traducir

Infusion Devices and Methods

NºPublicación: US2021398663A1 23/12/2021

Solicitante:

ABBOTT DIABETES CARE INC [US]

US_2022013224_A1

Resumen de: US2021398663A1

Medical devices, systems, and methods related thereto a glucose monitoring system having a first display unit in data communication with a skin-mounted assembly, the skin-mounted assembly including an in vivo sensor and a transmitter. The first display unit and a second display unit are in data communication with a data management system. The first display unit comprises memory that grants a first user first access level rights and the second display unit comprises memory that grants a second individual second access level rights.

traducir

METHOD AND APPARATUS FOR ELECTRICAL CURRENT THERAPY OR BIOLOGICAL TISSUE AND INSULIN RELEASE THEREFROM

NºPublicación: EP3924036A1 22/12/2021

Solicitante:

MOWER MORTON M [US]

WO_2020168164_A1

Resumen de: US2020261730A1

The present disclosure relates to a device for applying electrical stimulation to biological tissues. Specifically, the present disclosure is related to a device for applying anodal/cathodal biphasic electrical stimulation to beta cells of the pancreas. Through application of biphasic stimulation to beta cells of the pancreas, insulin secretion can be increased in an effort to overcome deficiencies associated with diabetic patients.

traducir

Insulin Management

NºPublicación: EP3926638A1 22/12/2021

Solicitante:

ASEKO INC [US]

JP_2019213866_A

Resumen de: US2015217053A1

A method of managing insulin includes receiving blood glucose measurements on a computing device from a glucometer. The blood glucose measurements are separated by a time interval. The method includes determining, using the computing device, an insulin dose rate based on the blood glucose measurements and determining a blood glucose drop rate based on the blood glucose measurements and the time interval. The method also includes determining a blood glucose percentage drop based on the blood glucose measurements. The method includes decreasing the time interval between blood glucose measurements by the glucometer when the blood glucose drop rate is greater than a threshold drop rate, and decreasing the time interval between blood glucose measurements by the glucometer when the blood glucose percentage drop is greater than a threshold percentage drop.

traducir

Safe insulin needle

NºPublicación: EP3925652A1 22/12/2021

Solicitante:

BERPU MEDICAL TECH CO LTD [CN]

KR_20210128419_PA

Resumen de: CN109718429A

The invention relates to a safe insulin needle. The insulin needle comprises a sheath, a needle tube, a safety sheath, a pressing seat and a needle seat; the needle tube is arranged on the central axis of the needle seat, the upper part of the needle seat is sleeved by the pressing seat, the whole body of the needle seat and the pressing seat is sleeved by the safety sheath, the upper part of thesafety sheath is connected and matched with the pressing seat, the needle tube penetrates out from the top end of the upper part of the safety sheath, the lower part of the safety sheath is connectedand matched with the lower part of the needle seat, the whole body of the safety sheath and the needle tube is sleeved by the sheath, and the lower part of the sheath is connected and matched with thelower part of the safety sheath. The method adds the pressing seat, redesigns the connecting structure of the pressing seat, the safety sheath and the needle seat, enhances the stability of the safety sheath on the axial plane while realizing the circumferential and axial self-locking of the safety sheath, ensures the stability of the whole structure, and improves the safety factor of the product. The whole product is small in volume, compact in matching among parts, high in matching degree and capable of being assembled at one time.

traducir

BLOOD GLUCOSE DISEASE MANAGEMENT SYSTEM

NºPublicación: US2021386382A1 16/12/2021

Solicitante:

CERCACOR LAB INC [US]

Resumen de: US2021386382A1

The disease management system can determine a measurement of one or more physiological parameters and can determine a disease event based on the one or more measurements. Furthermore, the disease management system can determine a pose of an individual using a pose sensor. Based on an identification of a disease event and a determination that the pose of the individual corresponds to a first pose, the disease management system can cause at least one of an audible, visual, or vibratory alarm. Based on an identification of a disease event and a determination that the pose of the individual does not correspond to the first pose, the disease management system can cause administration of a medication to the individual.

traducir

GAS STERILIZED CONTINUOUS METABOLIC MONITOR

NºPublicación: US2021386338A1 16/12/2021

Solicitante:

ZENSE LIFE INC [US]

WO_2021250527_A1

Resumen de: US2021386338A1

A metabolic analyte sensor includes a substrate having an electrically conductive surface, an interference layer on the conductive surface, an enzyme layer on the interference layer, and a glucose limiting layer on the enzyme layer. The interference layer or the enzyme layer is configured such that the metabolic analyte sensor has an improved performance characteristic after sterilization compared to before sterilization. A packaged continuous metabolic monitor includes a sealed container; a metabolic sensor in the sealed container for insertion into a patient after the metabolic sensor is removed from the sealed container, the metabolic sensor comprising a conductive surface and an enzyme layer; electronic operating circuitry in the sealed container and coupled to the metabolic sensor; and a residue of a sterilizing gas in the metabolic sensor. The sealed container, the metabolic sensor and the electronic operating circuitry are sterilized together in the sealed container using the sterilizing gas.

traducir

DETECTING MEAL INGESTION OR MISSED BOLUS

NºPublicación: WO2021253046A1 16/12/2021

Solicitante:

BIGFOOT BIOMEDICAL INC [US]

US_2021391052_A1

Resumen de: WO2021253046A1

A computer-implemented method of detecting a missed bolus comprises: receiving blood glucose values and bolus information regarding a person with diabetes, the blood glucose values and the bolus information relating to a period of time; classifying, based on the blood glucose values and the bolus information, each of multiple time periods within the period of time regarding whether the time period is associated with ingestion of a meal by the person; performing regression analysis on the classified multiple time periods to identify a first time period of the classified multiple time periods as corresponding to a beginning of the meal, wherein the bolus information indicates no bolus associated with the identified first time period; and associating, based on the regression analysis, a missed bolus event with the meal.

traducir

SYSTEMS, DEVICES, AND METHODS FOR IMPROVED ANALYTE SENSOR ACCURACY AND FAULT DETECTION

NºPublicación: WO2021252317A1 16/12/2021

Solicitante:

ABBOTT DIABETES CARE INC [US]

Resumen de: WO2021252317A1

Various embodiments of systems, devices and methods for improving the accuracy of an analyte sensor and for detecting sensor fault conditions are disclosed. According to some embodiments, these systems, devices, and methods can utilize a first data collected by a glucose sensor and a second data collected by a secondary sensing element. In some embodiments, the secondary sensing element can be one of a lactate sensing element, a ketone sensing element, or a heart rate monitor, among others.

traducir

METHODS, SYSTEMS, AND DEVICES FOR IMPROVED SENSORS FOR CONTINUOUS GLUCOSE MONITORING

NºPublicación: US2021386331A1 16/12/2021

Solicitante:

MEDTRONIC MINIMED INC [US]

WO_2021252168_A1

Resumen de: US2021386331A1

Methods, systems, and devices for continuous glucose monitoring. More particularly, the methods, systems, and devices describe a working electrode with a GOx sensor and a background electrode in which the background electrode has no GOx sensor. The system may then compare the first signal and the second signal to detect ingestion of a medication by the user. The system may generate a sensor glucose value based on the comparison.

traducir

SYSTEM AND METHOD FOR DETERMINING LIFESTYLE REGIME

NºPublicación: US2021386332A1 16/12/2021

Solicitante:

HEALTH ARX TECH PVT LTD [IN]

AU_2020231185_A1

Resumen de: US2021386332A1

Disclosed is system (100) for determining lifestyle regime for user, the system comprising: user device (102, 204, 300) comprising user agent module, wherein user agent module is configured to generate user interface (302), and receive user input data from user; blood glucose measuring device (104, 202) communicably coupled to user device for operation, blood glucose measuring device comprising electronic strip port for generating electronic signal; temperature sensor for sensing ambient temperature; and control unit configured to compute blood glucose level based on electronic signal and ambient temperature, data aggregating arrangement (106, 208) communicably coupled to user device for receiving blood glucose level and user input data provided by user agent module, and to process blood glucose level and user input data using one or more algorithms to determine lifestyle regime for user and display lifestyle regime on user interface of user device.

traducir

MEDIZINISCHE APPLIKATIONSVORRICHTUNG, ERFASSUNGSSTRUKTUR FÜR EINE MEDIZINISCHE APPLIKATIONSVORRICHTUNG, VERFAHREN ZUM KALIBRIEREN DERSELBEN UND VERFAHREN ZUM BETREIBEN DER MEDIZINISCHEN APPLIKATIONSVORRICHTUNG

NºPublicación: DE102020112097B4 16/12/2021

Solicitante:

PG40 CONSULTING GROUP GMBH [DE]
TECHNISCHE UNIV DRESDEN KOERPERSCHAFT DES OEFFENTLICHEN RECHTS [DE]

Resumen de: DE102020112097B4

Medizinische Applikationsvorrichtung (100) zur Verabreichung eines flüssigen Arzneimittels bereitgestellt, die medizinische Applikationsvorrichtung (100) aufweisend: ein Reservoir (104), das zum Aufnehmen des flüssigen Arzneimittels eingerichtet ist; eine Applikationsstruktur (106), die eingerichtet ist, das flüssige Arzneimittel aus dem Reservoir (104) in eine Applikationsvorrichtung-externe Umgebung (116) zu verabreichen; eine Dosiervorrichtung (108), die mit dem Reservoir (104) gekoppelt ist und eingerichtet ist, eine Dosis des flüssigen Arzneimittels in dem Reservoir (104) einzustellen, die in einer Anwendung der medizinischen Applikationsvorrichtung (100) verabreichbar ist, und zur Verabreichung der Dosis; eine Abstand-Erfassungsvorrichtung (114), die einen optischen Sendeempfänger aufweist, der eingerichtet ist, einen Abstand (118) zwischen der Applikationsstruktur (106) und der Applikationsvorrichtung-externen Umgebung (116) zu erfassen; eine Lage-Erfassungsvorrichtung (112), die eingerichtet ist, eine Lage (130) der medizinischen Applikationsvorrichtung (100) bezüglich der Applikationsvorrichtung-externen Umgebung (116) zu erfassen; und eine Dosis-Erfassungsvorrichtung (110), die eingerichtet ist, die zu verabreichende Dosis des flüssigen Arzneimittels und die Verabreichung der Dosis zu erfassen.

traducir

METHODS, SYSTEMS, AND IMPLANTABLE DEVICES FOR ENHANCING BLOOD GLUCOSE REGULATION

NºPublicación: US2021386333A1 16/12/2021

Solicitante:

UNIV ARIZONA [US]

AU_2021202373_A1

Resumen de: US2021386333A1

Methods, systems, and devices for regulating blood glucose such as implantable encapsulated devices optionally with insulin and/or glucagon secreting cells in combination with glucose sensors and insulin infusion systems. For example, encapsulation devices may be connected to an insulin infusion pump for distribution of insulin. The insulin infusion pump may feature an insulin pouch fluidly connected to an insulin pump (or a syringe) and a glucose sensor separate from the encapsulation device. The system may feature an additional implantable device comprising insulin and glucagon secreting cells.

traducir

GAS STERILIZED CONTINUOUS METABOLIC MONITOR

NºPublicación: WO2021250527A1 16/12/2021

Solicitante:

ZENSE LIFE INC [US]

US_2021386338_A1

Resumen de: WO2021250527A1

A metabolic analyte sensor includes a substrate having an electrically conductive surface, an interference layer on the conductive surface, an enzyme layer on the interference layer, and a glucose limiting layer on the enzyme layer. The interference layer or the enzyme layer is configured such that the metabolic analyte sensor has an improved performance characteristic after sterilization compared to before sterilization. A packaged continuous metabolic monitor includes a sealed container; a metabolic sensor in the sealed container for insertion into a patient after the metabolic sensor is removed from the sealed container, the metabolic sensor comprising a conductive surface and an enzyme layer; electronic operating circuitry in the sealed container and coupled to the metabolic sensor; and a residue of a sterilizing gas in the metabolic sensor. The sealed container, the metabolic sensor and the electronic operating circuitry are sterilized together in the sealed container using the sterilizing gas.

traducir

METHODS, SYSTEMS, AND DEVICES FOR IMPROVED SENSORS FOR CONTINUOUS GLUCOSE MONITORING

NºPublicación: WO2021252168A1 16/12/2021

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2021386331_A1

Resumen de: WO2021252168A1

Methods, systems, and devices for continuous glucose monitoring. More particularly, the methods, systems, and devices describe a working electrode with a GOx sensor and a background electrode in which the background electrode has no GOx sensor. The system may then compare the first signal and the second signal to detect ingestion of a medication by the user. The system may generate a sensor glucose value based on the comparison.

traducir

PREDICTIVE GUIDANCE SYSTEMS FOR PERSONALIZED HEALTH AND SELF-CARE, AND ASSOCIATED METHODS

NºPublicación: US2021391081A1 16/12/2021

Solicitante:

INFORMED DATA SYSTEMS INC D/B/A ONE DROP [US]

WO_2021247922_A1

Resumen de: US2021391081A1

Systems and methods for biomonitoring and personalized healthcare are disclosed herein. In some embodiments, a biomonitoring and healthcare guidance system is configured to generate personalized self-care recommendations (e.g., recommendations relating to sleep, exercise, diet, etc.) to guide a. patient in effectively managing and/or improving a chronic condition (e.g., diabetes, pre-diabetes, hypertension, hyperlipidemia, etc.). The system can continuously or periodically update and/or adapt the self-care recommendations (e.g., based on data from the particular patient as well as data from a plurality of other patients). The system can guide individuals toward self-care changes that are likely to improve their chronic health conditions, support them in making those changes, and adapt and/or update continuously over time.

traducir

INSULIN INJECTION ASSISTANCE SYSTEMS, METHODS, AND DEVICES

NºPublicación: US2021386936A1 16/12/2021

Solicitante:

BIGFOOT BIOMEDICAL INC [US]

US_2019184108_PA

Resumen de: US2021386936A1

One or more embodiments of the disclosure relate, generally, to a system to assist with manual dosing of insulin. Such a system may include a glucose sensor system, a reusable insulin dosing detector, and a recommendation system. The reusable insulin dosing detector may be configured to be reversibly connectable to a disposable component that may form part of an insulin manual delivery assembly. The reusable insulin dosing detector may be configured to detect insulin delivery associated with the insulin manual delivery assembly. The recommendation system may be configured to analyze blood glucose data and determine adjustments to insulin therapy settings.

traducir

DETECTING MEAL INGESTION OR MISSED BOLUS

NºPublicación: US2021391052A1 16/12/2021

Solicitante:

BIGFOOT BIOMEDICAL INC [US]

WO_2021253046_A1

Resumen de: US2021391052A1

A computer-implemented method of detecting a missed bolus comprises: receiving blood glucose values and bolus information regarding a person with diabetes, the blood glucose values and the bolus information relating to a period of time; classifying, based on the blood glucose values and the bolus information, each of multiple time periods within the period of time regarding whether the time period is associated with ingestion of a meal by the person; performing regression analysis on the classified multiple time periods to identify a first time period of the classified multiple time periods as corresponding to a beginning of the meal, wherein the bolus information indicates no bolus associated with the identified first time period; and associating, based on the regression analysis, a missed bolus event with the meal.

traducir

CLOSED-LOOP DIABETES TREATMENT SYSTEM DETECTING MEAL OR MISSED BOLUS

Nº publicación: US2021391050A1 16/12/2021

Solicitante:

BIGFOOT BIOMEDICAL INC [US]

WO_2021253045_A2

Resumen de: US2021391050A1

A computer-implemented method of performing closed-loop insulin therapy comprises: receiving blood glucose values and bolus information regarding a person with diabetes, the blood glucose values and the bolus information relating to a period of time; determining, based on the blood glucose values, the bolus information, and a meal size propensity record regarding the person, an amount of insulin for the person; and causing, in response to the determination, the amount of insulin to be administered to the person.

traducir

previousPage Página2 de 6 nextPage por página

punteroimgVolver